Meeting
2022 ASCO Annual Meeting
Mucinous adenocarcinoma of the anal canal: Clinical characteristics and outcomes of 767 patients from National Cancer Database.
Authors
Sam Melamed
The Lundquist Research Institute, Torrance, CA
Sam Melamed , Jin Sun Lee , Mykola Onyshchenko
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Colorectal and Anal
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Anal Cancer
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 3522)
DOI
10.1200/JCO.2022.40.16_suppl.3522
Abstract #
3522
Poster Bd #
316
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
A randomised phase II multicentre study of ipilimumab with temozolomide vs temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: Ipi-Glio.
First Author: Paul James Mulholland
Poster
2018 Gastrointestinal Cancers Symposium
The impact of the preoperative waiting period on the survival in patients with clinical stage II / III gastric cancer.
First Author: Furukawa Kenichiro
Poster
2014 ASCO Annual Meeting
Improved survival in an exhaustive population based on a cohort of liposarcoma (LPS) patients treated in expert centers according to clinical practice guidelines (CPG'S): Experience from Rhone Alpes (RA) region.
First Author: Olfa Derbel
Poster
2024 ASCO Genitourinary Cancers Symposium
Outcomes with neoadjuvant chemotherapy in bladder-preserving treatment for MIBC.
First Author: Michael Glover